30 results
8-K
EX-99.2
KNTE
Kinnate Biopharma Inc
17 Apr 23
Results of Operations and Financial Condition
3:15pm
regarding the potential benefits of the company’s product candidates, including KIN-7136 and KIN-8741; the timing for initiation, conduct of and goals
8-K
EX-10.1
hnslz4h3gy536ac8c5
7 Jun 21
Experienced leaders bring substantial clinical research, regulatory, and operational expertise in the biopharmaceutical industry to the Kinnate team
8:07am
10-Q
oslipvt
17 May 21
Quarterly report
4:26pm
DEF 14A
tm132zhj
30 Apr 21
Definitive proxy
9:13am
10-K
fgp0q6vzoii
29 Mar 21
Annual report
4:26pm
8-K
EX-99.1
ljnaa laeh
29 Mar 21
Kinnate Biopharma Inc. Reports Full Year 2020 Financial Results
4:15pm
424B4
1j9bdq h0v
3 Dec 20
Prospectus supplement with pricing info
4:48pm
S-1/A
EX-10.3
mp7xw1tbpu
30 Nov 20
IPO registration (amended)
6:05am